Firm Advises Lead Investor NEA on Inversago Pharma's $70 Million Series C

Retrieved on: 2022-10-26 09:05:10

Tags for this article:

Click the tags to see associated articles and topics

Firm Advises Lead Investor NEA on Inversago Pharma's $70 Million Series C. View article details on hiswai:

Excerpt

... announced the completion of a Series C funding of $95 million CAD (approximately $70 million USD) led by New Enterprise Associates (NEA).

Article found on: www.wsgr.com